119 related articles for article (PubMed ID: 11814312)
1. Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by PMN from cancer patients.
Jablonska E; Piotrowski L; Kiluk M; Jablonski J; Grabowska Z; Markiewicz W
Cytokine; 2001 Dec; 16(5):173-7. PubMed ID: 11814312
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
Jabłońska E; Izycka A; Wawrusiewicz N
Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
Jablonska E; Marcinczyk M
Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
[TBL] [Abstract][Full Text] [Related]
4. IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location.
Jablonska E; Jablonski J; Piotrowski L; Grabowska Z
Immunobiology; 2001 Dec; 204(4):508-16. PubMed ID: 11776404
[TBL] [Abstract][Full Text] [Related]
5. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.
Malyak M; Smith MF; Abel AA; Hance KR; Arend WP
J Immunol; 1998 Aug; 161(4):2004-10. PubMed ID: 9712073
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.
Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J
Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils.
Marie C; Pitton C; Fitting C; Cavaillon JM
Cytokine; 1996 Feb; 8(2):147-51. PubMed ID: 8777273
[TBL] [Abstract][Full Text] [Related]
8. iNOS expression and NO production by neutrophils in cancer patients.
Jabłońska E; Puzewska W; Marcińczyk M; Grabowska Z; Jabłoński J
Arch Immunol Ther Exp (Warsz); 2005; 53(2):175-9. PubMed ID: 15928587
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
10. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
11. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer.
Jabłońska E; Piotrowski L; Grabowska Z
Rocz Akad Med Bialymst; 1997; 42(1):99-106. PubMed ID: 9581469
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
Jabłońska E; Kiluk M; Markiewicz W; Piotrowski L; Grabowska Z; Jabłoński J
Arch Immunol Ther Exp (Warsz); 2001; 49(1):63-9. PubMed ID: 11266093
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
Jouvenne P; Vannier E; Dinarello CA; Miossec P
Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8.
Bouchard A; Ratthé C; Girard D
J Leukoc Biol; 2004 May; 75(5):893-900. PubMed ID: 14982947
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous secretion of interleukin 1 receptor antagonist (IL-1ra) by cells isolated from herniated lumbar discal tissue after discectomy.
Koch H; Reinecke JA; Meijer H; Wehling P
Cytokine; 1998 Sep; 10(9):703-5. PubMed ID: 9770331
[TBL] [Abstract][Full Text] [Related]
18. Differential synthesis of two interleukin-1 receptor antagonist variants and interleukin-8 by peripheral blood neutrophils.
Schröder AK; von der Ohe M; Fleischer D; Rink L; Uciechowski P
Cytokine; 2005 Dec; 32(5):246-53. PubMed ID: 16343927
[TBL] [Abstract][Full Text] [Related]
19. The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-Ra detection.
Roberge CJ; Poubelle PE; Beaulieu AD; Heitz D; Gosselin J
J Immunol; 1996 Jun; 156(12):4884-91. PubMed ID: 8648138
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
